Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study

  • Sara Bringhen
  • , Luděk Pour
  • , Reuben Benjamin
  • , Sebastian Grosicki
  • , Chang Ki Min
  • , Danielle Leao C． de Farias
  • , Alexander Vorog
  • , Richard J. Labotka
  • , Bingxia Wang
  • , Dasha Cherepanov
  • , Lauren E. Cain
  • , Sudhakar Manne
  • , S. Vincent Rajkumar
  • , Meletios A. Dimopoulos

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science